Show simple item record

dc.contributor.authorSkjåkødegård, Hanna Flækøy
dc.contributor.authorConlon, Rachel P. K.
dc.contributor.authorHystad, Sigurd William
dc.contributor.authorRoelants, Mathieu
dc.contributor.authorOlsson, Sven J. G.
dc.contributor.authorFrisk, Bente
dc.contributor.authorWilfley, Denise E.
dc.contributor.authorDanielsen, Yngvild Sørebø
dc.contributor.authorJuliusson, Pétur Benedikt
dc.date.accessioned2022-06-22T08:09:59Z
dc.date.available2022-06-22T08:09:59Z
dc.date.created2022-05-10T08:09:06Z
dc.date.issued2022
dc.identifier.issn1758-8103
dc.identifier.urihttps://hdl.handle.net/11250/2999957
dc.description.abstractTo compare the effectiveness of family-based behavioural social facilitation treatment (FBSFT) versus treatment as usual (TAU) in children with severe obesity. Parallel-design, nonblinded, randomized controlled trial conducted at a Norwegian obesity outpatient clinic. Children aged 6–18 years referred to the clinic between 2014 and 2018 were invited to participate. Participants were randomly allocated using sequentially numbered, opaqued, sealed envelopes. FBSFT (n = 59) entailed 17 sessions of structured cognitive behavioural treatment, TAU (n = 55) entailed standard lifestyle counselling sessions every third month for 1 year. Primary outcomes included changes in body mass index standard deviation score (BMI SDS) and percentage above the International Obesity Task Force cut-off for overweight (%IOTF-25). Secondary outcomes included changes in sleep, physical activity, and eating behaviour. From pre- to posttreatment there was a statistically significant difference in change in both BMI SDS (0.19 units, 95% confidence interval [CI]: 0.10–0.28, p < .001) and %IOTF-25 (5.48%, 95%CI: 2.74–8.22, p < .001) between FBSFT and TAU groups. FBSFT participants achieved significant reductions in mean BMI SDS (0.16 units, (95%CI: −0.22 to −0.10, p < .001) and %IOTF-25 (6.53%, 95% CI: −8.45 to −4.60, p < .001), whereas in TAU nonsignificant changes were observed in BMI SDS (0.03 units, 95% CI: −0.03 to 0.09, p = .30) and %IOTF-25 (−1.04%, 95% CI: −2.99 to −0.90, p = .29). More FBSFT participants (31.5%) had clinically meaningful BMI SDS reductions of ≥0.25 from pre- to posttreatment than in TAU (13.0%, p = .021). Regarding secondary outcomes, only changes in sleep timing differed significantly between groups. FBSFT improved weight-related outcomes compared to TAU.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleFamily-based treatment of children with severe obesity in a public healthcare setting: Results from a randomized controlled trialen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.source.articlenumbere12513en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1111/cob.12513
dc.identifier.cristin2022888
dc.source.journalClinical Obesityen_US
dc.relation.projectHelse Vest RHF: 911964en_US
dc.identifier.citationClinical Obesity. 2022, 12 (3), e12513.en_US
dc.source.volume12en_US
dc.source.issue3en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal